Julie Shimer - Avanos Medical Independent Director
AVNS Stock | USD 18.69 0.15 0.81% |
Director
Dr. Julie A. Shimer, Ph.D. serves as Independent Director of the Company. Dr. Shimer is the Chairman of the Compensation Committee. She is currently a private investor and has 30 years of product development experience, including many years with major communications companies. From March 2007 to April 2012 she served as Chief Executive Officer of Welch Allyn, Inc., a manufacturer of frontline medical products and solutions, having served on the board of directors beginning in July 2002. Previously, Dr. Shimer was President, Chief Executive Officer, and a member of the board of directors of Vocera Communications, Inc., a provider of wireless communications systems. She also has served as general manager at 3Com Corporation and Motorola and was a product development leader at Motorola and ATT Bell Laboratories. She has served as the Chairwoman of Empire State Development Corporationration, the State of New Yorks economic development organization, and as an advisor to two private companies, Kitchology, a mobile platform empowering families dealing with special diets through the power of technology and community, and CPLANE Networks, a leader in endtoend data center and wide area network service orchestration that enables softwaredefined networking and network function virtualization services to be launched and managed in a single environment. She also serves on the boards of directors of three nonprofit organizations. Dr. Shimer serves as a director of Netgear, Inc., a provider of home and small business network solutions, Windstream Holdings, Inc., a leading telecommunications and cloud services provider, and Apollo Endosurgery, Inc., a medical device company focused on less invasive therapies for the treatment of obesity, and Masimo Corporationrationration, a medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies. since 2014.
Age | 68 |
Tenure | 10 years |
Address | 5405 Windward Parkway, Alpharetta, GA, United States, 30004 |
Phone | 844 428 2667 |
Web | https://avanos.com |
Julie Shimer Latest Insider Activity
Tracking and analyzing the buying and selling activities of Julie Shimer against Avanos Medical stock is an integral part of due diligence when investing in Avanos Medical. Julie Shimer insider activity provides valuable insight into whether Avanos Medical is net buyers or sellers over its current business cycle. Note, Avanos Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Avanos Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Julie Shimer over six months ago Acquisition by Julie Shimer of 5354 shares of Avanos Medical subject to Rule 16b-3 |
Avanos Medical Management Efficiency
The company has return on total asset (ROA) of 0.0208 % which means that it generated a profit of $0.0208 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0177 %, meaning that it created $0.0177 on every $100 dollars invested by stockholders. Avanos Medical's management efficiency ratios could be used to measure how well Avanos Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0.09). At this time, Avanos Medical's Total Current Assets are comparatively stable compared to the past year. Intangibles To Total Assets is likely to gain to 0.63 in 2024, whereas Net Tangible Assets are likely to drop slightly above 181.9 M in 2024.Similar Executives
Showing other executives | DIRECTOR Age | ||
Joel Suiter | SurModics | N/A | |
Aimee Weisner | Glaukos Corp | 51 | |
Michael DeMane | Nevro Corp | 63 | |
Shawn McCormick | Nevro Corp | 56 | |
Jean Hobby | Integer Holdings Corp | 60 | |
Cheryl Blanchard | Anika Therapeutics | 60 | |
Fred Hite | Orthopediatrics Corp | 56 | |
Martha Aronson | CONMED | 53 | |
James Hinrichs | Integer Holdings Corp | 53 | |
David Bronson | CONMED | 67 | |
Gilbert Kliman | Glaukos Corp | 61 | |
Jerome Lande | CONMED | 45 | |
Charles Farkas | CONMED | 68 | |
Jeffrey Burbank | Artivion | 58 | |
Brian Concannon | CONMED | 62 | |
Kevin OBoyle | Nevro Corp | 62 | |
Donald Spence | Integer Holdings Corp | 67 | |
Frank Fischer | Nevro Corp | 78 | |
Pamela Bailey | Integer Holdings Corp | 72 | |
Alvin Jeffers | Integer Holdings Corp | 47 | |
David Hoffmeister | Glaukos Corp | 66 |
Management Performance
Return On Equity | 0.0177 | ||||
Return On Asset | 0.0208 |
Avanos Medical Leadership Team
Elected by the shareholders, the Avanos Medical's board of directors comprises two types of representatives: Avanos Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avanos. The board's role is to monitor Avanos Medical's management team and ensure that shareholders' interests are well served. Avanos Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avanos Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Cato, Vice Resources | ||
S Mansbach, Senior Vice President Interim General Counsel, Corporate Secretary | ||
William Haydon, Senior Vice President and General Manager, Pain Management | ||
Moji James, Senior Vice President General Counsel | ||
Patrick OLeary, Independent Director | ||
Sigfrido Delgado, Senior Chain | ||
Julie Shimer, Independent Director | ||
Michelle Scharfenberg, Senior Vice President Chief Ethics and Compliance Officer | ||
Gary Blackford, Independent Non-Executive Chairman of the Board | ||
William Hawkins, Independent Director | ||
David Ball, Senior Vice President - Global Supply Chain and Procurement | ||
Mojirade James, Senior Vice President General Counsel, Corporate Secretary | ||
Heidi Kunz, Independent Director | ||
Lee Burnes, Clinical RD | ||
Michael Greiner, Chief Financial Officer, Senior Vice President | ||
Scott Galovan, Vice Development | ||
Michael CPA, Senior CEO | ||
Sudhakar Varshney, Senior Procurement | ||
John Byrnes, Independent Director | ||
Maria Sainz, Independent Director | ||
David Crawford, VP Treasurer | ||
Arjun Sarker, Senior Vice President - International | ||
John Hurley, Principal Controller | ||
Kerr Holbrook, Senior Vice President General Manager - Chronic Care | ||
Joseph Woody, Chief Executive Officer, Director |
Avanos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avanos Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0177 | ||||
Return On Asset | 0.0208 | ||||
Profit Margin | 0.02 % | ||||
Operating Margin | 0.1 % | ||||
Current Valuation | 972.14 M | ||||
Shares Outstanding | 45.96 M | ||||
Shares Owned By Insiders | 2.97 % | ||||
Shares Owned By Institutions | 96.14 % | ||||
Number Of Shares Shorted | 614.53 K | ||||
Price To Earning | 51.23 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.